Schroder Investment Management Group
CGON icon

Schroder Investment Management Group’s CG Oncology CGON Stock Holding History

Schroder Investment Management Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Sell
28,837
-127,490
-82% -$8.33M ﹤0.01% 917
2026
Q1 		$10M Sell
156,327
-124,732
-44% -$7.07M 0.01% 663
2025
Q4 		$11.3M Buy
281,059
+135,725
+93% +$5.62M 0.01% 616
2025
Q3 		$5.68M Sell
145,334
-118,705
-45% -$3.45M ﹤0.01% 752
2025
Q2 		$6.87M Buy
264,039
+155,737
+144% +$3.75M 0.01% 706
2025
Q1 		$2.86M Buy
+108,302
New +$3.05M ﹤0.01% 857

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group's CGON Position: Q2 2026 in Review

Schroder Investment Management Group reduced its CG Oncology (CGON) stake by 82% in Q2 2026, selling an estimated $8.33M and leaving 28,837 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Schroder Investment Management Group first reported a position in CGON in Q1 2025 and has held it in 6 quarters since. The position peaked at $11.3M in Q4 2025. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Schroder Investment Management Group held 28,837 shares of CG Oncology worth $2.13M as of Q2 2026.
  • Schroder Investment Management Group sold 127,490 CG Oncology shares in Q2 2026, an estimated $8.33M.
  • CG Oncology made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #917 holding.
  • Schroder Investment Management Group first reported a position in CG Oncology in Q1 2025 and has held it in 6 quarters since.
  • Schroder Investment Management Group's CG Oncology position peaked at $11.3M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.